# A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

> **NCT01907828** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 61 (actual)

## Conditions studied

- Persistent Atrial Fibrillation
- Paroxysmal Atrial Fibrillation
- Hypertension

## Interventions

- **DEVICE:** Renal Artery Ablation
- **DEVICE:** Cardiac Ablation

## Key facts

- **NCT ID:** NCT01907828
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-15
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-10-15
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2020-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01907828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01907828, "A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01907828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*